🔗 Permalink

Inventor profile of:

Pascal Deschatelets

City:

Louisville, Kentucky

Country:

United States

Published Applications:

Last publication date:

2016-07-28

Top Assignees for applications by Pascal Deschatelets

The entities that hold a legal rights for patent applications filed by inventor Deschatelets Pascal:

APELLIS PHARMACEUTICALS, INC. 9 Crestwood, KY United States
POTENTIA PHARMACEUTICALS, INC. 6 Louisville, KY United States
POTENTIA PHARMACEUTICALS, INC. 3 Crestwood, KY United States
LUNA INNOVATIONS INCORPORATED 2 Roanoke, VA United States
APELLIS AG 1 Louisville, KY United States
President and Fellows of Harvard College 1 Cambridge, MA United States
Luna Innovations Incorporation 1 Blacksburg, VA United States

Recent patent applications by Deschatelets Pascal

Pascal Deschatelets from Louisville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-07-28

US20160215020A1

Chemistry; metallurgy

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

#2 | 2016-07-07

US20160194359A1

Chemistry; metallurgy

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#3 | 2016-03-10

US20160067357A1

Human necessities

DETECTION OF HIGH RISK DRUSEN

#4 | 2015-06-04

US20150150945A1

Human necessities

Modifying Macrophage Phenotype for Treatment of Disease

#5 | 2014-12-18

US20140371133A1

Human necessities

Methods of treating chronic disorders with complement inhibitors

#6 | 2014-10-30

US20140323407A1

Chemistry; metallurgy

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

#7 | 2014-02-20

US20140050739A1

Human necessities

LOCAL COMPLEMENT INHIBITION FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

#8 | 2013-12-05

US20130324482A1

Chemistry; metallurgy

COMPSTATIN ANALOGS FOR TREATMENT OF RHINOSINUSITIS AND NASAL POLYPOSIS

#9 | 2013-11-07

US20130296254A1

Human necessities

Method of treating age-related macular degeneration comprising administering a compstatin analog

#10 | 2013-08-08

US20130203678A1

Human necessities

Compstatin analogs for treatment of neuropathic pain

#11 | 2012-09-06

US20120225114A1

Human necessities

Modifying Macrophage Phenotype for Treatment of Disease

#12 | 2012-05-31

US20120135430A1

Physics

Complement assays and uses thereof

#13 | 2011-08-04

US20110190221A1

Human necessities

MODULATION AND REPLETION/ENHANCEMENT OF THE COMPLEMENT SYSTEM FOR TREATMENT OF TRAUMA

#14 | 2011-07-28

US20110182877A1

Human necessities

SUSTAINED DELIVERY OF COMPSTATIN ANALOGS FROM GELS

#15 | 2011-04-21

US20110092446A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMA

#16 | 2010-07-01

US20100166862A1

Human necessities

Local complement inhibition for treatment of complement-mediated disorders

#17 | 2009-09-03

US20090220572A1

Chemistry; metallurgy

Injectable Combination Therapy for Eye Disorders

#18 | 2009-05-07

US20090117171A1

Human necessities

Compositions and methods for treatment of macular degeneration and related conditions

#19 | 2007-12-27

US20070295395A1

Electricity

Photovoltaic Device With Trimetaspheres

#20 | 2007-10-11

US20070238654A1

Chemistry; metallurgy

Methods of treating age-related macular degeneration by compstatin and analogs thereof

#21 | 2007-06-21

US20070142202A1

Performing operations; transporting

Fabrication of ceramic microstructures

#22 | 2006-11-16

US20060257359A1

Human necessities

Modifying macrophage phenotype for treatment of disease

#23 | 2006-06-29

US20060142191A1

Human necessities

Viral complement control proteins for eye disorders

#24 | 2006-02-21

US10829443

Flame retardant thermoset resins and methods of making the same

#25 | 2005-09-15

US20050203224A1

Chemistry; metallurgy

Flame-retardant synthetic resin articles containing flame-retardant superabsorbent polymer (SAP) particles

#26 | 2005-05-26

US20050113297A1

Human necessities

Compositions and methods for enhancing phagocytosis or phagocyte activity

InventorID:

378333 ⎘